J. Müller, L. Nitschke: The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease. In: Nature reviews. Rheumatology. Band 10, Nummer 7, Juli 2014, S. 422–428, doi:10.1038/nrrheum.2014.54, PMID 24763061.
T. Dörner, A. Shock, D. M. Goldenberg, P. E. Lipsky: The mechanistic impact of CD22 engagement with epratuzumab on B cell function: Implications for the treatment of systemic lupus erythematosus. In: Autoimmunity Reviews. Band 14, Nummer 12, Dezember 2015, S. 1079–1086, doi:10.1016/j.autrev.2015.07.013, PMID 26212727.
nih.gov
ncbi.nlm.nih.gov
J. Müller, L. Nitschke: The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease. In: Nature reviews. Rheumatology. Band 10, Nummer 7, Juli 2014, S. 422–428, doi:10.1038/nrrheum.2014.54, PMID 24763061.
T. Tsubata: Role of inhibitory BCR co-receptors in immunity. In: Infectious disorders drug targets. Band 12, Nummer 3, Juni 2012, S. 181–190, PMID 22394175.
T. Dörner, A. Shock, D. M. Goldenberg, P. E. Lipsky: The mechanistic impact of CD22 engagement with epratuzumab on B cell function: Implications for the treatment of systemic lupus erythematosus. In: Autoimmunity Reviews. Band 14, Nummer 12, Dezember 2015, S. 1079–1086, doi:10.1016/j.autrev.2015.07.013, PMID 26212727.
